Drug Type Small molecule drug |
Synonyms Atorvastatin/sitagliptin, Sitagliptin/Atorvastatin |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC66H76CaF2N4O13 |
InChIKeyHIZONJHAVINWOX-NIJVSVLQSA-N |
CAS Registry344423-98-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Phase 3 | DE | - | |
Atherosclerosis | Phase 3 | - | - | |
Diabetes Mellitus | Phase 3 | - | - | |
Diabetes Mellitus | Phase 3 | HU | - | |
Diabetes Mellitus | Phase 3 | BG | - | |
Diabetes Mellitus | Phase 1 | DE | - |